Search

Hauser, RA, H Barkway, HH Fernandez, SA Factor, J Jimenez-Shahed, N Gross, L Marinelli, et al. 2022. “Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study. 2022 Feb 23;13:773999. Doi: 10.3389/Fneur.2022.773999. ECollection 2022. PMID: 35280262.”. Front Neurol.

Hauser, RA, H Barkay, A Wilhelm, M Wieman, JM Savola, and MF Gordon. 2022. “Minimal Clinically Important Change in Abnormal Involuntary Movement Scale Score in Tardive Dyskinesia As Assessed in Pivotal Trials of Deutetrabenazine. 2022 Mar 2;97:47-51. Doi: 10.1016. Epub 2022 Mar 2.PMID: 35299070.”. Parkinsonism Relat Disord.

Hauser, RA, J Lytle, AE Formella, and CM Tanner. 2022. “Amantadine Delayed Release/Extended Release Capsules Significantly Reduce OFF Time in Parkinson’s Disease. 2022 Mar 18;8(1):29. Doi: 10.1038/S41531-022-00291-1. PMID: 35304480.”. NP J Parkinsons Dis.

Nam, Young-Jae, Kunhua Song, Xiang Luo, Edward Daniel, Kaleb Lambeth, Katherine West, Joseph A Hill, et al. 2013. “Reprogramming of Human Fibroblasts Toward a Cardiac Fate.”. Proceedings of the National Academy of Sciences of the United States of America 110 (14): 5588-93.

Song, Kun-Hua, Yong-Feng Jin, Yao-Wei Huang, Yao-Zhou Zhang, and Lian Yu. 2000. “Infectious Bursal Disease Virus Structural Protein VP2 Expressed by a Baculovirus Recombinant in Bombyx Mori.”. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica et Biophysica Sinica 32 (3): 281-84.

Camilleri, M, T Subramanian, F Pagan, S Isaacson, R Gil, RA Hauser, M Feldman, and M Goldstein. 2022. “Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial. 2022 Dec;175(12):1666-1674. Doi: 10.7326/M22-1438. Epub 2022 Nov 8. PMID: 36343348”. Ann Intern Med.

Hauser, RA, PA LeWitt, CH Waters, DG Grosset, and B Blank. 2023. “The Clinical Development of Levodopa Inhalation Powder. 2023 Mar-Apr 01;46(2):66-78. Doi: 10.1097/WNF.0000000000000540. Epub 2023 Jan 29. PMID: 36715241”. Clin Neuropharmacol.

“Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy. American Journal of Human Genetics, 104(6), 1210–1222.”. 2019. American Journal of Human Genetics.

Aradi, SD, and RA Hauser. 2020. “Medical Management and Prevention of Motor Complications in Parkinson’s Disease. Neurotherapeutics 2020;17:1339-1365.”. Neurotherapeutics.

Mills, KA, RB Schneider, M Saint-Hilaire, GW Ross, RA Hauser, AE Lang, MJ Halverson, et al. 2020. “Cognitive Impairment in Parkinson’s Disease: Associations Between Subjective and Objective Cognitive Decline in a Large Longitudinal Study. Parkinsonism Relat Disord 2020;80:127-132.”. Parkinsonism Relat Disord.